The above 15 psychedelic drug stocks increased, on average, by 32.3% during the first week of January, 2021, building on the 58.4% increase in December and 48.7% in November. That being said, were the out-sized gain by Jaguar excluded from the index the increases would have been +46.4% in November, +69.1% in December and -0.8% during the first week of January.

When "big pharma" realizes the potential of psychedelics in treating mental health issues many of the companies identified in this article will be bought out and those that remain should see their stock prices continue to undergo major appreciation. Do your own due diligence and to determine if any of these stocks belong in your portfolio.